On Friday, August 24th, as part of our involvement in the accelerator program organized by MIT Poland, we are participating in a meeting during ... More

Gazeta Wrocławska: Bioceltix develops biological drugs for common pet diseases. At the moment, the company is working on drugs for locomotor ... More

Scientists, experts and entrepreneurs from Wroclaw have been recognized in the Most Creative Minds in Business Ranking published by Brief ... More

Wrocław scientists in the comfort of laboratories are preparing drugs that change the standards of treating dogs, cats and horses. Just a little ... More

The Jury of the 8th edition of The 50 Most Creative in Business ranking has decided – Łukasz Bzdzion, Bioceltix CEO, took the second place. The ... More

As the first company in Europe, Bioceltix intends to authorize a veterinary biopharmaceutical based on stem cells. Łukasz Bzdzion, the CEO of the ... More

We was on Impact’18, congress that brings leaders at the forefront of innovation from many sectors together to explore the opportunities ... More

CEO of Bioceltix, Łukasz Bzdzion, during the WallStreet conference in Karpacz talked about the AlloMSCs technology, biopharmaceuticals based on ... More

Ranking The 50 Most Creative in Business is an initiative that for 7 years has been helping to build and promote the innovative and creative ... More

– We are the first company in Europe to develop and implement animal-safe and business-scale technology that uses allogeneic stem cells in ... More